Previous Article | Next Article 
Clinical and Diagnostic Laboratory Immunology, July 2004, p. 770-774, Vol. 11, No. 4
1071-412X/04/$08.00+0 DOI: 10.1128/CDLI.11.4.770-774.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
HLA Class II Profile and Distribution of HLA-DRB1 and HLA-DQB1 Alleles and Haplotypes among Lebanese and Bahraini Arabs
Wassim Y. Almawi,1* Marc Busson,2 Hala Tamim,3 Einas M. Al-Harbi,1 Ramzi R. Finan,4 Saria F. Wakim-Ghorayeb,5 and Ayesha A. Motala6
Al-Jawhara Center for Molecular Medicine, Genetics and Inherited Diseases, Arabian Gulf University, Manama, Bahrain,1
Hopital St. Louis, Paris, France,2
Faculty of Health Sciences, American University of Beirut,3
Departments of Obstetrics and Gynecology,4
Endocrinology, St. Georges University Hospital, Beirut, Lebanon,5
Nelson R. Mandela School of Medicine, University of Natal, Durban, South Africa6
Received 19 January 2004/
Returned for modification 24 March 2004/
Accepted 27 April 2004

ABSTRACT
The gene frequencies of HLA class II alleles were studied in
95 healthy Lebanese Arab and 72 healthy Bahraini Arab subjects.
Our aim was to establish the genetic relationship between Bahraini
and Lebanese Arabs in terms of HLA class II gene and haplotype
frequencies and to compare these results with frequencies for
other countries with populations of Caucasian and non-Caucasian
descent. Subjects were unrelated and of both sexes, and HLA-DRB1
and -DQB1 genotyping was done by the PCR sequence-specific primer
technique. Comparative analysis of the HLA-DR and -DQ alleles
revealed differences in the allelic distribution among Bahraini
and Lebanese subjects. Analysis of the 25 HLA-DRB1 alleles that
have been investigated showed that the DRB1*040101 and DRB1*110101
alleles were more frequent among Lebanese, whereas DRB1*030101
and DRB1*160101 alleles were more frequent among Bahrainis.
Similarly, of the seven HLA-DQB1 alleles analyzed, the presence
of DQB1*0201 was more frequent among Bahrainis, whereas DQB1*030101
was more frequent among Lebanese. The DRB1*160101-DQB1*050101
(0.1318 versus 0.0379%) and DRB1*030101-DQB1*0201 (0.1202 versus
0.0321%) haplotypes were more frequent among Bahrainis, while
the DRB1*110101-DQB1*030101 (0.3142 versus 0.1198%) and DRB1*040101-DQB1*0302
(0.1416 versus 0.0278%) haplotypes were more frequent in Lebanese
subjects. Furthermore, a high prevalence of the DRB1*040101-DRB1*110101-DQB1*0302-DQB1*030101
(12.63 versus 1.35%,
P = 0.015) and the homozygous DRB1*110101-DRB1*110101-DQB1*030101-DQB1*030101
(7.37 versus 0.00%,
P = 0.046) genotypes was seen among Lebanese,
and DRB1*070101-DRB1*160101-DQB1*0201-DQB1*050101 (6.76 versus
0.00%,
P = 0.034) was seen more frequently among Bahraini subjects.
Our results underline significant differences between these
two populations in HLA class II distribution, provide basic
information for further studies of major histocompatibility
complex heterogeneity among Arabic-speaking countries, and serve
as a reference for further anthropological studies.

INTRODUCTION
The major histocompatibility complex (MHC) plays a key role
in self-nonself recognition and is broadly divided into highly
polymorphic class I (HLA-A, -B, and -C) and class II (HLA-DP,
-DQ, and -DR) loci, which are subdivided into distinct regions
(refer to the IMGT/MLA database for up-to-date listings of these
genes [23]). For example, HLA-DRB1, with more than 315 known
alleles, and DPB1, with more than 99 alleles (
19), represent
the most polymorphic protein-encoding regions of the human genome
(
19,
23). In addition to their role in conferring immune identity,
genetic distances and correspondence analysis demonstrated that
patterns of allele and haplotype distribution of class I and
class II loci are racially and geographically restricted, thereby
allowing their use for population and evolution studies (
8,
21).
Comparative analysis of the HLA class II DR and DQ alleles and haplotypes has revealed differences in the distribution of these alleles among different ethnic groups and reflected ancient and recent admixtures between different populations (9, 21, 25). This has significant implications for analyzing human migration trends throughout history (14). Studies of the HLA origin of Arabs are scanty, but studies of related eastern and western Mediterranean groups including Turks, Iranians, Jews, Lebanese, and others suggest a common ancestry (6, 8, 24). Variation in HLA class II distribution among these populations can be explained by the admixture of the ancient population with invading and migratory societies, which may have given rise to present-day racial and ethnic groups (8).
In view of the heterogeneity of the Arab population, which comprises people of distinct ethnic backgrounds and whose origins can be classified according to their area of habitation (North Africa, Arabian peninsula, and eastern Mediterranean), the present study was aimed at elucidating the diversity in HLA class II allele distribution among two distinct Arab communities, Bahrain and Lebanon. Bahrain is an island located in the Arabian Gulf whose inhabitants derive their origin from three major roots: Jaafari Arabs, Sunni Arabs, and Iranians (4). Lebanon is located in the eastern Mediterranean, and its population consists of Christians (Catholic, Maronite, Greek Orthodox, and Coptic) and Moslems (Sunni, Shiite, and Druze). This study provides basic information for further studies of the MHC differences between Arabs of distinct origins and will serve as a reference for further anthropological studies, as well as for studies of associations between HLA and disease.

MATERIALS AND METHODS
Subjects.
The samples used in this study included 95 healthy unrelated
Lebanese subjects, with a mean age of 29.8 ± 12.1 years
(range, 3 to 56 years), of whom 50 were females and 45 were
males. Lebanese participants were of an Arab origin (no Armenian
or similar non-Arab Lebanese were included) and from the five
provinces of the country, representing the major religious groups
and sects. In addition, 72 healthy unrelated Bahrainis, with
a mean age (± standard deviation) of 28.4 ± 13.4
years (range, 10 to 64 years), of whom 39 were females and 33
were males, were included in the study. Biochemical profiles
(serum glucose, cholesterol, high-density lipoprotein-cholesterol,
low-density lipoprotein-cholesterol, and triglycerides) were
similar between Bahraini and Lebanese subjects (
P = not significant),
and none of the participants had a personal or family history
of autoimmunity (in particular diabetes), hyperlipidemia, or
cardiovascular disorders, thereby avoiding bias in selection
of study participants. Participants (or guardians for subjects
of <16 years of age) were asked to sign a consent form according
to the protocol of the study, and all institutional ethics requirements
were met.
HLA genotyping.
Total genomic DNA was extracted from the peripheral blood mononuclear leukocytes from study participants by the phenol-chloroform method, as is standard, and was used for PCR analysis. HLA-DRB1 and -DQB1 gene alleles were analyzed using the PCR sequence-specific priming (SSP) technique, using the SSP2L HLA class II (DRB-DQB) genotyping kit according to the specifications of the manufacturer (One Lambda, Thousand Oaks, Calif.). PCR products were analyzed on a 2.5% (wt/vol) agarose gel stained with ethidium bromide (0.5 µg/ml).
Data analysis.
Allele frequencies were determined as described previously (31) with the HLAStat 2000 software, which also computed the P values and odds ratios (OR). Linkage analysis, the nonrandom association between DRB1 and DQB1 alleles as defined by the delta (D') coefficient, was calculated as described previously (26) also by using the HLAStat 2000 software. The frequencies of the most frequent haplotypes were determined by the maximum likelihood method, with use of the Arlequin (v. 2000) population genetics data analysis software (S. Schneider, D. Roessli, and L. Excoffier, University of Geneva, Geneva, Switzerland, 2000; http://anthro.unige.ch/arlequin).P values were corrected for the number of different alleles tested (Pc) by the Bonferroni inequality method (10), and significance was determined at P < 0.05. Wright's FST analogue (30) was used to assess population differentiation, calculations being made using GenAlEx software (R. Peakall and P. E. Smouse, Australian National University, Canberra, Australia, 2001; http://www.anu.edu.au/BoZo/GenAlEx/), which was also used to calculate Nei genetic distance and identity. Additional statistical analysis was performed with the SPSS version 11.5 for Windows statistical package.

RESULTS
Frequencies of the HLA-DRB1 alleles.
We found significant DRB1 allelic differences between Lebanese
and Bahraini Arabs, 7 of 25 loci being significantly different
(
P < 0.05). When we applied the Bonferroni correction, differences
were significant for four loci. These comprised DRB1*030101
(0.139 versus 0.032%;
Pc = 0.033) and DRB1*160101 (0.139 versus
0.037%;
Pc = 0.01), which were significantly more frequent in
Bahraini than in Lebanese subjects (Table
1), and DRB1*040101
(0.179 versus 0.049%;
Pc = 0.002) and DRB1*110101 (0.368 versus
0.160%;
Pc = 0.003), which were more frequent among Lebanese
than among Bahraini subjects (Table
1).
Frequencies of the HLA-DQB1 alleles.
Similarly, significant DQB1 allelic differences were seen between
Lebanese and Bahraini Arabs, four of seven loci being significantly
different (
P < 0.05). With the Bonferroni correction, differences
were significant for only two loci. These comprised DQB1*0201
(0.257 versus 0.158%;
Pc < 0.001; OR = 4.267), which was
more frequent among Bahraini than among Lebanese subjects (Table
2), and DQB1*030101 (0.379 versus 0.160%;
Pc < 0.001; OR
= 0.245), which was more frequent among Lebanese than among
Bahraini subjects (Table
2).
Linkage analysis.
While the complete results for the two-locus analysis could
not be presented due to space constraints, linkage analysis
revealed that DRB1*010101 was found with DQB1*0201 among Lebanese
but not Bahraini subjects (Table
3). DQB1*050101 was in linkage
with DRB1*010101, -040101, -070101, and -140101 among Bahraini
subjects, as were DRB1*160101-DQB1*030101 and DRB1*110101-DQB1*060101
(Table
3).
Frequencies of DRB1-DQB1 haplotypes.
The distribution of the HLA DRB1-DQB1 haplotypes in healthy
Bahraini and Lebanese participants was next assessed. The frequencies
of DRB1*030101-DQB1*0201 (0.1202 versus 0.0321%;
P = 0.004;
OR = 4.11) and DRB1*160101-DQB1*050101 (0.1318 versus 0.0379%;
P = 0.007, OR = 3.97) were higher among Bahraini than among
Lebanese subjects (Table
4). In contrast, the frequencies of
DRB1*040101-DQB1*0302 (0.1416 versus 0.0278%;
P < 0.001;
OR = 0.17) and DRB1*110101-DQB1*030101 (0.3142 versus 0.1198%;
P < 0.001; OR = 0.29) were higher among Lebanese than among
Bahraini subjects (Table
4).
DRB1-DQB1 genotype distribution.
Genotype analysis revealed that the DRB1*040101/110101-DQB1*0302/030101
(12.63 versus 1.35%;
P = 0.015; OR = 10.55) and the homozygous
DRB1*110101/110101-DQB1*030101/030101 (7.37 versus 0.00%;
P = 0.046) genotypes were observed more frequently in Lebanese
than in Bahraini subjects (Table
5). Among the Bahraini subjects
tested, extensive heterogeneity was seen in genotype distribution,
with DRB1*070101/160101
-DQB1*0201/050101 (6.76 versus 0.00%;
P = 0.034) appearing to be most commonly present (Table
5).
HLA class II diversity.
The differences at the HLA class II DRB and DQB loci were further
investigated using F
ST and Nei genetic distance and identity
measurements. When class II alleles from Bahraini and Lebanese
Arabs were compared, overall average genetic differentiation
between populations (estimated with the F
ST, a measure of genetic
differentiation over subpopulations) was 0.026 for DRB1 and
0.029 for DQB1 (Table
6). Nei genetic distance and identity
were 0.287 and 0.751, respectively. Collectively, this suggested
that the identity between Bahraini and Lebanese Arabs was not
high.

DISCUSSION
Analysis of HLA genes has provided invaluable tools for anthropological
studies, and analysis of HLA loci and haplotypes, first by serology
and later by molecular tools, has been reported for many societies.
Insofar as Arabs represent a heterogeneous mixture of populations
extending from the Arabian (Persian) Gulf to the Atlantic Ocean,
and in view of the admixture brought about by the transmigration
which trans-Arabia has witnessed throughout its history, this
study was undertaken to analyze HLA class II usage among Bahraini
and Lebanese Arab communities, the former situated in the eastern
Arabian peninsula and the latter located in the eastern Mediterranean.
As expected, marked heterogeneity in HLA class II DR-DQ alleles and haplotypes was seen, with DRB1*030101 and DQB1*0201 being more prevalent among Bahrainis while DRB1*110101/040101 and DQB1*030101 were more prevalent among Lebanese Arabs, and also by genotype analysis, which clearly showed that the DRB1*040101-DRB1*110101-DQB1*0302-DQB1*030101 and DRB1*110101-DRB1*110101-DQB1*030101-DQB1*030101 genotypes were more frequent among Lebanese, while DRB1*070101-DRB1*160101-DQB1*0201-DQB1*050101 was more common among Bahrainis. This heterogeneity in HLA class II expression was subsequently confirmed by analysis of molecular variance and FST measurements and also by calculating Nei genetic distance and identity, all of which indicated that the identity between these two populations was not high.
Among the DRB1 alleles analyzed we noted that DRB1*110101, a common allele of eastern Mediterranean countries including Greece, Bulgaria (16), Turkey (25) and Slovakia (12), had the highest frequency among Lebanese. In addition to the DRB1*110101 allele which they shared with the Lebanese, Bahrainis also had unique DRB1 alleles including DRB1*030101 and DRB1*160101, which were present at significantly lower frequencies among healthy Lebanese. The similarity of the Lebanese alleles to those of the above-mentioned eastern Mediterranean countries as well as other countries, including Algeria (13) and Hungary (29), may be explained by the admixture brought about by the migration of Phoenicians (ancestors of present-day Lebanese) to North Africa and southern Europe.
Analysis of the Bahraini HLA class II alleles and haplotypes revealed some relatedness to their Lebanese counterparts and also to those of neighboring and distant ethnic groups, as exemplified by DRB1*1101 and DRB1*16011 (6, 27), which suggests the influence of these populations on this distinct Arab population. The strongest similarity that the Bahrainis had was with their related Arabian Gulf neighbors, as exemplified with DRB1*030101, which is also highly frequent among healthy Saudi (2) and Kuwaiti (3, 15) Arabs. Interestingly, the same alleles were highly frequent among Iranians (5), Indians (20), and Thais (28), an indication that Bahraini Arabs share some HLA components with populations of the Arabian Peninsula and the Indian subcontinent.
Perhaps the main feature of Arabs is the high diversity of DR-DQ associations. Most of the DRB-DQB associations reported here for both Bahraini and Lebanese Arabs were also seen in other regions, though at different frequencies. These included DRB1*0701-DQB1*0201, which was common among Yemenite Jews (17), Moroccans (17), and Iranians (5); DRB1*0401-DQB1*0302, reported for Jordanian Arabs (24); and DRB1*1501-DQB1*06, which was reported for Tunisians (1). There were also certain haplotypes which were completely missing among these two Arabic-speaking populations but reported for other ethnic groups, including DRB1*0803-DQB1*0601 for Filipinos (11), DRB1*0401-DQB1*0401 for Koreans (22), and DRB1*16-DQB1*0602 for Japanese (7).
Data presented here, in defining the HLA profile among (eastern Mediterranean) Lebanese and (Arabian Peninsula) Bahraini Arabs, point to differences in the origins of these two distinct Arabic-speaking communities, brought about possibly by the admixture of the original inhabitants with neighboring and distant populations. These results provide information that can be used for future anthropological studies and also in the analysis of disease susceptibility and organ transplantation (18, 22).

FOOTNOTES
* Corresponding author. Mailing address: Al-Jawhara Center for Molecular Medicine, Genetics and Inherited Diseases, College of Medicine and Medical Sciences, Arabian Gulf University, P.O. Box 22979, Manama, Bahrain. Phone: 973-39 71 71 18. Fax: 973-17 271 090. E-mail:
wyalmawi{at}yahoo.co.uk.


REFERENCES
1 - Abid Kamoun, H., S. Hmida, H. Kaabi, A. Abid, H. Slimane Houissa, M. Maamar, N. Mojaat, L. Ben Hamed, A. Dridi, M. Kamoun Zribi, K. Nagati, A. Haddad, and K. Boukef. 2002. HLA polymorphism in type 1 diabetes Tunisians. Ann. Genet. 45:45-50.[Medline]
2 - Al-Arfaj, A. S. 2001. Characteristics of rheumatoid arthritis relative to HLA-DR in Saudi Arabia. Saudi Med. J. 22:595-598.[Medline]
3 - al-Harbi, S., F. Fouad, and S. A. Kaaba. 1994. The first HLA anthropological study in the Kuwaiti population. Eur. J. Immunogenet. 21:295-300.[Medline]
4 - Al-Mahroos, F., and P. M. McKeigue. 1998. High prevalence of diabetes in Bahrainis. Associations with ethnicity and raised plasma cholesterol. Diabetes Care 21:936-942.[Abstract]
5 - Amirzargar, A., J. Mytilineos, S. Farjadian, M. Doroudchi, S. Scherer, G. Opelz, and A. Ghaderi. 2001. Human leukocyte antigen class II allele frequencies and haplotype association in Iranian normal population. Hum. Immunol. 62:1234-1238.[CrossRef][Medline]
6 - Arnaiz-Villena, A., M. Karin, N. Bendikuze, E. Gomez-Casado, J. Moscoso, C. Silvera, F. S. Oguz, A. Sarper Diler, A. De Pacho, L. Allende, J. Guillen, and J. Martinez Laso. 2001. HLA alleles and haplotypes in the Turkish population: relatedness to Kurds, Armenians and other Mediterraneans. Tissue Antigens 57:308-317.[CrossRef][Medline]
7 - Awata, T., T. Kuzuya, A. Matsuda, Y. Iwamoto, and Y. Kanazawa. 1992. Genetic analysis of HLA class II alleles and susceptibility to type 1 (insulin-dependent) diabetes mellitus in Japanese subjects. Diabetologia 35:419-424.[CrossRef][Medline]
8 - Ayala, F. J. 1995. The myth of Eve: molecular biology and human origins. Science 270:1930-1936.[Free Full Text]
9 - Benitez, O., P. Loiseau, M. Busson, C. Dehay, J. Hors, F. Calvo, M. Durand Mura, and D. Charron. 2002. Hispano-Indian admixture in Paraguay studied by analysis of HLA-DRB1 polymorphism. Pathol. Biol. (Paris) 50:25-29.[Medline]
10 - Bland, J. M., and D. G. Altman. 1995. Multiple significance tests: the Bonferroni method. Br. Med. J. 310:170.[Free Full Text]
11 - Bugawan, T. L., W. Litz, M. Alejandrino, J. Ching, A. Panelo, C. M. Solfelix, A. Petrone, R. Buzzetti, P. Pozzilli, and H. A. Erlich. 2002. The association of specific HLA class I and II alleles with type 1 diabetes among Filipinos. Tissue Antigens 59:452-469.[CrossRef][Medline]
12 - Cechova, E., H. Fazekasova, S. Ferencik, I. Shawkatova, and M. Buc. 1998. HLA-DRB1, -DQB1 and -DPB1 polymorphism in the Slovak population. Tissue Antigens 51:574-576.[Medline]
13 - Djoulah, S., A. Sanchez-Mazas, I. Khalil, S. Benhamamouch, L. Degos, I. Deschamps, and J. Hors. 1994. HLA-DRB1, DQA1 and DQB1 DNA polymorphisms in healthy Algerian and genetic relationships with other populations. Tissue Antigens 43:102-109.[Medline]
14 - Erlich, H. A., S. J. Mack, T. Bergstrom, and U. B. Gyllensten. 1997. HLA class II alleles in Amerindian populations: implications for the evolution of HLA polymorphism and the colonization of the Americas. Hereditas 127:19-24.[CrossRef][Medline]
15 - Haider, M. Z., M. A. Zahid, H. N. Dalal, and M. A. Razik. 2000. Human leukocyte antigen (HLA) DRB1 alleles in Kuwaiti Arabs with schizophrenia. Am. J. Med. Genet. 96:870-872.[CrossRef][Medline]
16 - Ivanova, R., E. Naoumova, V. Lepage, S. Djoulah, Y. Yordanov, M. N. Loste, and D. Charron. 1996. HLA-DRB1, DQA1, DQB1 DNA polymorphism in the Bulgarian population. Tissue Antigens 47:122-126.[Medline]
17 - Izaabel, H., H. J. Garchon, S. Caillat-Zucman, G. Beaurain, O. Akhayat, J. F. Bach, and A. Sanchez-Mazas. 1998. HLA class II DNA polymorphism in a Moroccan population from the Souss, Agadir area. Tissue Antigens 51:106-110.[Medline]
18 - Lee, J. E., J. Abdalla, G. A. Porter, L. Bradford, E. A. Grimm, J. D. Reveille, P. F. Mansfield, J. E. Gershenwald, and M. I. Ross. 2002. Presence of the human leukocyte antigen class II gene DRB1*1101 predicts interferon gamma levels and disease recurrence in melanoma patients. Ann. Surg. Oncol. 9:587-593.[CrossRef][Medline]
19 - Marsh, S. G., E. D. Albert, W. F. Bodmer, R. E. Bontrop, B. Dupont, H. A. Erlich, D. E. Geraghty, J. A. Hansen, B. Mach, W. R. Mayr, P. Parham, E. W. Petersdorf, T. Sasazuki, G. M. Schreuder, J. L. Strominger, A. Svejgaard, and P. I. Terasaki. 2002. Nomenclature for factors of the HLA system, 2002. Tissue Antigens 60:407-464.[CrossRef][Medline]
20 - Mehra, N. K., A. G. Bouwens, A. Naipal, R. Rajalingam, Z. Grubic, V. Taneja, M. G. Tilanus, and M. J. Giphart. 1994. Asian Indian HLA-DR2-, DR4-, and DR52-related DR-DQ genotypes analyzed by polymerase chain reaction based nonradioactive oligonucleotide typing. Unique haplotypes and a novel DR4 subtype. Hum. Immunol. 39:202-210.[CrossRef][Medline]
21 - Mobini, N., E. J. Yunis, C. A. Alper, J. J. Yunis, J. C. Delgado, D. E. Yunis, A. Firooz, Y. Dowlati, K. Bahar, P. K. Gregersen, and A. R. Ahmed. 1997. Identical MHC markers in non-Jewish Iranian and Ashkenazi Jewish patients with pemphigus vulgaris: possible common central Asian ancestral origin. Hum. Immunol. 57:62-67.[CrossRef][Medline]
22 - Park, Y. S., C. Y. Wang, K. W. Ko, S. W. Yang, M. Park, M. C. Yang, and J. X. She. 1998. Combinations of HLA DR and DQ molecules determine the susceptibility to insulin-dependent diabetes mellitus in Koreans. Hum. Immunol. 59:794-801.[CrossRef][Medline]
23 - Robinson, J., M. J. Waller, P. Parham, N. de Groot, R. Bontrop, L. J. Kennedy, P. Stoehr, and S. G. E. Marsh. 2003. IMGT/HLA and IMGT/MHC: sequence databases for the study of the major histocompatibility complex. Nucleic Acids Res. 31:311-314.[Abstract/Free Full Text]
24 - Sanchez-Velasco, P., N. S. Karadsheh, A. Garcia-Martin, C. Ruiz de Alegria, and F. Leyva-Cobian. 2001. Molecular analysis of HLA allelic frequencies and haplotypes in Jordanians and comparison with other related populations. Hum. Immunol. 62:901-909.[CrossRef][Medline]
25 - Saruhan-Direskeneli, G., F. A. Uyar, S. Bakar, and M. Eraksoy. 2000. Molecular analysis of HLA-DRB1, DQA1 and -DQB1 polymorphism in Turkey. Tissue Antigens 55:171-174.[CrossRef][Medline]
26 - Svejgaard, A., and L. P. Ryder. 1994. HLA and disease associations: detecting the strongest association. Tissue Antigens 43:18-27.[Medline]
27 - Tang, T. F., J. Wang, R. Slack, Y. S. Lin, L. Li, U. Heine, J. Ng, R. J. Hartzman, and C. Katovich Hurley. 2002. DRB1*03 diversity and DRB3 associations in five major population groups in the United States. Hum. Immunol. 63:221-228.[CrossRef][Medline]
28 - Trejaut, J., K. Bhatia, W. D. Greville, K. R. Hu, G. Duraisamy, C. Nuchprayoon, J. Donald, A. Aziz, and H. Dunckley. 1996. HLA-DR2 haplotypic diversity in populations of South-East Asia, northern China, Melanesia and Australian aborigines using PCR-RFLP for DRB1, DRB5, DQA1 and DQB1. A novel DRB1 allele: DRB1*16022. Eur. J. Immunogenet. 23:437-449.[Medline]
29 - Varga, E., E. Endreffy, G. Samu, E. Szekeres, F. Toth, O. Bede, and I. B. Petri. 1996. Molecular genetic analysis of HLA-DRB, -DQA, and -DQB polymorphisms in Hungarians and distribution of the DRB1*03 allele in adults and newborns. Exp. Clin. Immunogenet. 13:204-209.[Medline]
30 - Weir, B. S., and W. G. Hill. 2002. Estimating F-statistics. Annu. Rev. Genet. 36:721-750.[CrossRef][Medline]
31 - Yasuda, N., and M. Kimura. 1968. A gene-counting method of maximum likelihood for estimating gene frequencies in ABO and ABO-like systems. Ann. Hum. Genet. 31:409-420.[Medline]
Clinical and Diagnostic Laboratory Immunology, July 2004, p. 770-774, Vol. 11, No. 4
1071-412X/04/$08.00+0 DOI: 10.1128/CDLI.11.4.770-774.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Al-Jenaidi, F. A., Wakim-Ghorayeb, S. F., Al-Abbasi, A., Arekat, M. R., Irani-Hakime, N., Najm, P., Al-Ola, K., Motala, A. A., Almawi, W. Y.
(2005). Contribution of Selective HLA-DRB1/DQB1 Alleles and Haplotypes to the Genetic Susceptibility of Type 1 Diabetes among Lebanese and Bahraini Arabs. J. Clin. Endocrinol. Metab.
90: 5104-5109
[Abstract]
[Full Text]